Kuan-Ting Liu

Title: Kuan-Ting Liu: Innovator in Immunology

Introduction

Kuan-Ting Liu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunology, particularly in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). His innovative methods have the potential to enhance our understanding of immune responses to this virus.

Latest Patents

Kuan-Ting Liu holds a patent for a method that determines immune competence against SARS-CoV-2. This method involves obtaining a blood sample from a subject, detecting levels of binding antibodies against the SARS-CoV-2 spike S1 protein and its receptor binding domain (RBD), and calculating a weighted value using a regression model. This patent represents a crucial advancement in the assessment of immune responses to COVID-19.

Career Highlights

Throughout his career, Kuan-Ting Liu has been associated with prestigious institutions such as Chang Gung University and Chang Gung Memorial Hospital in Linkou. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant research initiatives.

Collaborations

Kuan-Ting Liu has worked alongside Guang-Wu Chen, further enhancing the collaborative efforts in his research endeavors.

Conclusion

Kuan-Ting Liu's innovative work in immunology, particularly regarding SARS-CoV-2, showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against infectious diseases.